$CL

What's Going on With Colgate-Palmolive Stock Friday? - Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive (NYSE:CL) reported base business EPS of 99 cents, up 8%, beating a 95-cent estimate, and net sales of $5.361 billion, slightly above expectations. Gross margin rose to 61.5%. North America sales fell 3% and management said tariff increases would outweigh refunds, pressuring shares, which were down 1.48% to $90.24.

Original reporting
Published Jul 31, 2026, 3:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 4:24 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
What's Going on With Colgate-Palmolive Stock Friday? - Colgate-Palmolive (NYSE:CL) — source image
Decision brief

The 30-second read

$CLBearishMed
01

Why it matters

Despite adjusted earnings and revenue beating estimates, the stock fell as investors prioritized North America weakness and management’s view that tariff increases would outweigh tariff refunds. Guidance was maintained for net sales growth but base business EPS growth was raised, and gross margin is expected to be roughly flat.

02

Market read

Traders likely reprice CL around tariff sensitivity and North America demand/share risk, even with improved base EPS outlook.

03

What to watch

Latin America and Asia Pacific growth were strong (Latin America +13.7%, AP +4.9%), and gross margin expanded on productivity and pricing, which could cushion earnings if North America stabilizes.

Relevance 7/10Novelty 6/10Timing: post-close Friday, after-hours sentiment shift from earnings and tariff commentary

Background

The article summarizes Colgate-Palmolive’s earnings and guidance, emphasizing margin drivers and regional performance, with a focus on tariff headwinds.

Company-level read

Ticker impact

$CLBearishMedium confidence
Context

Colgate reported base EPS and net sales beats, but North America sales fell 3% and tariff headwinds offset the earnings upside.

Expected impact

Choppy to downside-biased trading likely as investors focus on North America weakness and tariff net impact despite raised base EPS growth guidance.

Evidence & confidence

The article highlights a concrete regional miss (North America -3%) and a specific tariff dynamic (tariff increases more than offset refunds) that outweighed the earnings beat, while guidance was only partially improved (base EPS mid-single digits, gross margin flat).

Market effects

Consumer staples peers with similar North America exposure may see read-across risk if tariff pass-through and regional share losses persist.

North America demand and retailer inventory dynamics are the key regional swing factor highlighted for CL.

Tariff policy uncertainty is framed as a cross-region margin driver, with refunds only partially offsetting increased tariff costs.

Counterpoint

The company beat on base business metrics and raised base EPS growth guidance, suggesting the tariff impact may be more manageable than the market fears.

Key entities

  • Colgate-Palmolive

    Reported base business EPS and net sales beats, but North America sales declined and tariff headwinds pressured sentiment; updated base EPS guidance.

Related articles

$CLMed

Colgate-Palmolive Reaffirms Sales Forecast On Weak Demand

Colgate-Palmolive reaffirmed its annual net sales forecast despite a quarterly rise, citing weak North America demand. In the quarter ended June 30, net sales rose 4.9% to $5.36 billion and adjusted EPS was 99 cents. North America organic sales fell 3%, with volumes down 3.9%. The company expects 2026 adjusted earnings growth in mid-single digits and warned tariffs could offset refunds.

$CLMed

Colgate-Palmolive: Base Business EPS Increases 8% As Gross Margin Expands 140 Basis Points

Colgate-Palmolive reported Q2 2026 Base Business diluted EPS up 8% to $0.99 from $0.92, driven by 140 bps gross-margin expansion to 61.5% and higher organic sales. Reported diluted EPS fell 5% to $0.86 due to $129m pretax charges tied to its Strategic Growth and Productivity Program. Net sales rose 4.9% to $5.36b. Full-year organic outlook 1% to 4%; Base Business EPS expected mid-single-digit growth.

$CLMed

Colgate-Palmolive Q2 Earnings Call Highlights

Colgate-Palmolive (NYSE:CL) CFO Stan Sutula said Q2 material costs were slightly below expectations due to higher raw-material costs offset by tariff refunds, with no meaningful additional refunds expected. Management now expects full-year gross margin roughly flat, and warned second-half raw-material and tariff costs will be higher. It plans elevated ad spending and North America share recovery; Hill’s organic sales rose 4% excluding discontinued private-label.

$CLHighAI 9/10

Colgate-Palmolive Q2 2026 slides: strong results fuel raised guidance

Colgate-Palmolive (NYSE:CL) reported Q2 2026 results on July 31. Net sales rose 4.9% to $5.36B and organic sales grew 2.4%. Base EPS increased 8% and free cash flow rose 18% YoY to $1.5B YTD. The company raised 2026 guidance, including flat gross margin outlook and higher EPS growth, and projected $350M to $550M pre-tax charges for its 2030 program.

$CLMed

Colgate-Palmolive Lifts FY26 Adj. Earnings View, Despite Weak Q2 Profit; Stock Down

Colgate-Palmolive reported Q2 net earnings of $693 million, down from $743 million a year earlier, with EPS falling to $0.86 from $0.91. Net sales rose to $5.361 billion. The company confirmed FY2026 outlook and raised Base Business EPS growth to mid-single-digit from low- to mid-single-digit, and expects gross margin roughly flat. Shares were down about 2.78% premarket.

$CLMed

Colgate-Palmolive reaffirms annual sales forecast on weak North America demand

Amazon shares rally as cloud growth surges and spending outlook climbs July 31 (Reuters) - Colgate-Palmolive on Friday reaffirmed its annual sales forecast even after posting a quarterly rise as the toothpaste maker continues to grapple with muted demand in North America, sending its shares down 2.5%. Higher food and fuel prices tied to the Middle East conflict have hit lower-income shoppers hard, making it harder for U.S.